Schwartz Matthew Wilson has filed 5 insider transactions across 2 companies since November 2022.
Most recent transaction: a grant/award of 3333 shares of IMAC Holdings, Inc. ($BACK) on December 31, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2024 | IMAC Holdings, Inc. | $BACK | Schwartz Matthew Wilson | Director | A | Common Stock, no par value | 3333 | $0.00 | 3,333.0000 | 0 | 9999.99% | 0.00% |
| Nov. 29, 2022 | THERALINK TECHNOLOGIES, INC. | $THER | Schwartz Matthew Wilson | Director | J | 10% O.I.D. Senior Secured Convertible Debenture | 120999 | $0.00 | 120,999.0000 | 0 | 9999.99% | 0.00% |
| Nov. 29, 2022 | THERALINK TECHNOLOGIES, INC. | $THER | Schwartz Matthew Wilson | Director | J | 8% Convertible Promissory Note | 105216 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 29, 2022 | THERALINK TECHNOLOGIES, INC. | $THER | Schwartz Matthew Wilson | Director | J | Common Stock Purchase Warrant | 34571111 | $0.00 | 34,571,111.0000 | 0 | 9999.99% | 0.00% |
| Nov. 29, 2022 | THERALINK TECHNOLOGIES, INC. | $THER | Schwartz Matthew Wilson | Director | J | Common Stock Purchase Warrant | 4201681 | $0.00 | 4,201,681.0000 | 0 | 9999.99% | 0.00% |